Pazdan Christopher 4

What Happened

Christopher Pazdan, Chief Operating Officer of KORU Medical Systems, had 5,327 shares issued upon the vesting/conversion of restricted stock units (RSUs) on May 14, 2026. No purchase price was paid for those shares (issued at $0.00). To satisfy tax withholding obligations, 1,470 of those shares were withheld (disposed) at $3.94 per share, totaling $5,792. Net shares delivered to Pazdan after withholding: 3,857.

Key Details

• Transaction date: 2026-05-14; Filing date: 2026-05-18 (report covers the 5/14/2026 transaction).
• Issuance: 5,327 shares acquired upon vesting of RSUs (code M / footnote F1). Acquisition price shown as $0.00.
• Withholding: 1,470 shares withheld to satisfy tax obligations (code F / footnote F2) at $3.94 per share = $5,792.
• Net shares retained by insider after withholding: 3,857 (5,327 issued − 1,470 withheld).
• Shares owned following the transaction: Not disclosed in the provided filing.
• Notable footnotes: F1 = shares issued upon vesting of restricted stock units; F2 = shares withheld for taxes.
• Timeliness: Filing shows transaction date 5/14/2026 and was filed 5/18/2026; no late filing flag indicated.

Context

• This was a vesting/issuance of RSUs (a non-cash award), not a market purchase—common executive compensation practice.
• The withholding of shares to cover taxes is routine and effectively a cashless tax withholding, not a market-sale decision by the insider.
• Such awards are informational about compensation but do not necessarily signal the insider’s view of the company’s stock.